Objective Prevalence rates of depression and anxiety in patients with Multiple Sclerosis
(MS) vary widely across studies. Aim of this systematic review and meta-analysis was to a) …

Depressive disorders occur in up to 50% of people living with multiple sclerosis (MS).
Prevalence estimates are generally 2–3-times higher than those of the general population …

Clinically significant depression can affect up to 50% of patients with multiple sclerosis over
the course of their lifetime. It is associated with an increased morbidity and mortality and is …

Objective Emerging evidence suggests that comorbidity may influence disability outcomes in
multiple sclerosis (MS); we investigated the association between psychiatric comorbidity and …

Objective: To evaluate the direct and indirect influences of physical comorbidity, symptoms
of depression and anxiety, fatigue, and disability on health-related quality of life (HRQoL) in …

Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease. Motor,
sensory and cognitive deficits in MS are commonly accompanied by psychiatric disorders …

Background Anxiety, depression and reduction of quality of life (QoL) are common in people
with multiple sclerosis (pwMS). Fear of getting sick from COVID-19, government's lockdown …

Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis.
It remains a major cause of neurological disability in young and middle-aged adults suffering …

Objective: To make evidence-based recommendations for screening, diagnosing, and
treating psychiatric disorders in individuals with multiple sclerosis (MS). Methods: We …

The aim of this study was to investigate the prevalence of symptoms of depression and
anxiety amongst multiple sclerosis (MS) patients, and the associations with demographic …